Faeth Therapeutics
Faeth Therapeutics develops PIKTOR, an oral combination of PI3K and mTOR inhibitors, in clinical-stage testing for endometrial and breast cancer through multi-pathway inhibition.
SCHEDULE 13GNov 16Latest SEC filing
Nov 13Latest story
November 2026
October 2026
September 2026
August 2026
July 2026